期刊
CRITICAL CARE
卷 21, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s13054-017-1775-1
关键词
Autophagy; Glycaemic control; Hyperglycaemia; Immunometabolism; Insulin; Critical Illness; Sepsis; Glycolysis; Metabolism
There is an ongoing debate regarding the efficacy of glycaemic control in critically ill patients. Here we briefly highlight the key function of elevated glucose in critically ill patients, namely, to enable elevation of aerobic glycolysis in rapidly dividing cells. In particular, aerobic glycolysis provides metabolic intermediates necessary for expansion of biomass in immune cells and promotion of tissue repair. Furthermore, we emphasise that insulin may inhibit autophagy, a cell survival process used in the bulk degradation of cellular debris and damaged organelles. These observations provide a rational basis for tolerating elevated glucose levels in certain critically ill patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据